- > Media & Investors
- > Media Relations
- > Press Releases
- > Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology 10th Annual Clinical Pharmacology Research Award
For Immediate Release
Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Sunao Manabe, Representative Director, President and COO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology 10th Annual Clinical Pharmacology Research Award
Tokyo, Japan (June 16, 2017) – Daiichi Sankyo Company, Limited today announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology* (headquarters, Tokyo; Director General, Joji Nakayama), has awarded its 10th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers.
Award recipients are selected from research papers submitted from projects funded with subsidies from the foundation, and innovative research projects with expectations for future development are eligible for the award.
The Foundation hopes that this award will motivate young clinical pharmacology researchers who are involved in the establishment of innovative drug treatments and encourage future research results. The awards ceremony and presentation of research themes will be held on November 21, 2017.
*The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and has worked on a variety of projects relating to clinical pharmacology, including promotion of research and overseas studies for Japanese researchers.